Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization. - Wikidata - awgldk - TriplyDB

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

http://www.wikidata.org/entity/Q33694084

about

Gene therapy in the cornea: 2005--present.Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.Vector delivery technique affects gene transfer in the cornea in vivo Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: an in vitro study Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear.Research on mouse model of grade II corneal alkali burn Strategies for local gene therapy of corneal allograft rejection.

P2860

Q30459643-5700499E-2A52-448A-9ADD-8D4AFF04290B Q33886878-3DB08257-DC37-4483-A64E-A1E34A862397 Q34381465-61409F18-9993-4198-8EFF-3AAE0F949BB6 Q35158244-6759BAA8-F64B-46F9-8D00-780542D44686 Q35637218-58F5DF0E-C858-4860-9107-AF04CA37D0CD Q35891550-91C601CD-5EC7-4C77-A19A-FC8283EA52B0 Q36013013-8CB8895F-AB1F-49A9-9A01-5BFF340D4880 Q38098508-D85FAC02-34EE-429E-9069-4CEB87F1AD67

P2860

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

http://www.wikidata.org/entity/Q33694084

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

@ast

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

@en

type

label

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

@ast

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

@en

prefLabel

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

@ast

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

@en

P1433

Q33694084-2CE5D6E7-62D8-419B-A435-9C6F70AD8742

P1476

Q33694084-BC442C02-E3D8-4937-9BD4-B832323DF727

P2093

Q33694084-28DC3A1C-CB16-4BAB-BD76-DF438A5A7EA7

Q33694084-32283473-4BB6-47E5-AF84-3CFD7427D714

Q33694084-B9B64606-8BAB-4014-9B76-E5E1447BC45C

Q33694084-D713FA01-A397-4527-9667-13273AB0EECD

Q33694084-DE03766B-A915-44BB-AD10-07380C903E4B

Q33694084-F772718F-2107-4A0F-A963-425E8ECAB41D

Q33694084-FA85B4EF-7976-4A2A-A6D3-E55580E705FB

P2860

Q33694084-0EAD6EDE-8D6C-4D30-8DB3-6AF19572B550

Q33694084-18C79FA0-C1BB-4677-92C2-5374B459677D

Q33694084-1F3597C4-4A33-4E28-8B9D-11A18B5A8A22

Q33694084-1FD896B7-5E56-40A4-A1A8-8DBCA3C5ED3D

Q33694084-218B2EB6-7123-4E96-AB1B-98D1A8343CA1

Q33694084-21AD9ADA-382D-447B-8E9D-92AC3511666C

Q33694084-292B0683-8A4D-40D2-B237-B0911CBDAD21

Q33694084-2B727582-D828-415A-865B-AB0D6A79F46B

Q33694084-31B9AEC2-7E18-4A93-A072-6A6E2BF32184

Q33694084-35D41659-6F9F-4186-B5BF-FAE7E80F5FF5

P304

Q33694084-4724DE89-EDED-48F1-8E1F-35110C3D46CE

P31

Q33694084-F56E3D20-511A-4446-BE00-DB6F0CCDE332

P478

Q33694084-8386858E-F0F1-41A2-A1EC-53AF0CC24AA7

P577

Q33694084-00DE9B27-8156-4636-923F-B853D5763E87

P698

Q33694084-8488D0F4-8245-49FE-9062-C3369F2FF618

P921

Q33694084-983C798C-498D-447F-BEE3-3CE449E6CB8C

P932

Q33694084-E4DFCD11-058C-4933-B33F-2389AEEBDB28

P1433

Molecular Vision

P1476

Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

@en

P2093

Hongmei Yin

http://www.w3.org/2001/XMLSchema#string

Jing Mi

http://www.w3.org/2001/XMLSchema#string

Lixin Xie

http://www.w3.org/2001/XMLSchema#string

Peng Chen

http://www.w3.org/2001/XMLSchema#string

Wenxiao He

http://www.w3.org/2001/XMLSchema#string

Yao Wang

http://www.w3.org/2001/XMLSchema#string

Yiqiang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice

Biologic basis for interleukin-1 in disease

Leukocytes in the early events of corneal neovascularization.

Liposome-anchored vascular endothelial growth factor aptamers.

P304

310-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20208988

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

2830023

http://www.w3.org/2001/XMLSchema#string